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ABSTRACT  
Diffusion-weighted imaging (DWI) allows the assessment of the water apparent diffusion 
coefficient (ADC), a measure of tissue water diffusivity which is altered during different 
pathological conditions such as cerebral oedema. By means of DWI, we repeatedly 
measured in the same rats apparent diffusion coefficient ADC in different brain areas 
(motor cortex (MCx), somato-sensory cortex (SCx), caudate-putamen (CPu), hippocampus 
(Hip), mesencephalic reticular formation (RF), corpus callosum (CC) and cerebellum (Cb)) 
after 1 week, 4 and 12 weeks of lead acetate exposure via drinking water (50 or 500 ppm). 
After 12 weeks of lead exposure rats received albumin-Evans blue complex administration 
and were sacrified one hour later. Blood-brain barrier permeability and water tissue content 
were determined in order to evaluate their relationship with ADC changes. Chronic 
exposure to lead acetate (500 ppm) for 4 weeks increased ADC values in Hip, RF and Cb 
but no in other brain areas. After 12 weeks of lead acetate exposure at 500 ppm ADC is 
significantly increased also in CPu and CC. Brain areas displaying high ADC values after 
lead exposure showed also an increased water content and increased BBB permeability to 
Evans blue-albumin complex. Exposure to 50 ppm for 12 weeks increased ADC values and 
BBB permeability in the RF and Cb. In summary, chronic lead exposure induces cerebral 
oedema in the adult brain depending on the brain area and the dose of exposure. RF and Cb 
appeared the most sensitive brain areas whereas cerebral cortex appears resistant to lead-
induced cerebral oedema. 
KEY WORDS: lead neurotoxicity, vasogenic oedema, blood-brain barrier, reticular 
formation, apparent diffusion coefficient, magnetic resonance imaging  
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Introduction 
Lead (Pb) neurotoxicity is still a major medical concern in both environmental and 
occupational settings (CDC 2000). The clinical effects of acute and chronic lead toxicity 
are well documented (Davis et al. 1993, Grandjean 1993). Acute lead intoxication induces 
oedema in the brain of humans and laboratory animals (Goldstein et al., 1974; Holtzman et 
al., 1982; Hossain et al., 2004; Lögdberg et al., 1988; Pentschew, 1965; Villeda-Hernández 
et al., 2006; Winder et al., 1983; Winder 1984 for review). Two main types of cerebral 
oedema have been described, namely, vasogenic and cytotoxic oedema. Vasogenic oedema 
can be induced when water entries into the brain following an alteration of blood-brain 
barrier (BBB) permeability thus leading to an accumulation of water in the extracellular 
space (Klatzo 1967). In cytotoxic oedema (also called cellular oedema), water 
accumulation occurs inside the cells mainly in astrocytes (Klatzo 1967). 
It has been reported that acute lead intoxication in children and perinatal lead exposure in 
young animals cause cerebral oedema, in particular, vasogenic oedema (Hossain et al., 
2004; Lefauconnier  et al., 1983;Villeda-Hernández et al., 2006). Cytotoxic oedema has 
also been reported in one study (Lefauconnier et al., 1983). Different brain areas display 
different vulnerability to lead-induced cerebral oedema in young animals. Lead exposure 
(160 or 320 ppm in the drinking water) from gestational day 1 to gestational day 21 dose-
dependently induce interstitial/vasogenic oedema in different brain regions of rat fetuses 
such as parietal cortex, striatum, thalamus and cerebellum (Villeda-Hernandez et al., 2006) 
while Hossain et al. (2004) reported that cerebellum is the more susceptible brain region to 
lead-induced oedema in newborn rats. One of the events that contribute to vasogenic 
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oedema formation in the brain is the increase of BBB permeability.  
Vasogenic oedema resulting from BBB failure causes transvascular leak of blood proteins 
(albumin, fibrinogen, fibronectin and immunoglobulins) with concurrent oncotic influx of 
water and failure of compensatory mechanisms of fluid homeostasis. According to the 
proposed link between alteration of BBB permeability and the occurrence of vasogenic 
oedema, it has been shown in young animals that lead exposure impairs BBB permeability 
(Hossain et al., 2004; Sundstrom and Kalimo 1987; Sundstrom et al., 1985; Wang et al., 
2007). 
Moreover, several reports have demonstrated that lead accumulates not only in BBB 
endothelial cells (Struzynska et al., 1997; Toews et al., 1978) but also in the choroid plexus 
(Friedheim et al., 1983; Manton et al., 1984; Zheng et al., 1991) where it increases the 
leakage of the blood-cerebrospinal fluid barrier (Shi and Zheng 2007). These findings 
suggest that the mechanisms involved in brain water homeostasis might be altered during 
lead exposure. 
Magnetic resonance imaging (MRI) is a non invasive tool that provides information about 
changes in cerebral function in brain in vivo. MRI is the ideal modality to characterize the 
temporal and spatial evolutions of neuropathologies in vivo. Among different parameters 
that could be analyzed by MRI, diffusion weighted imaging (DWI) allows to calculate the 
apparent diffusion coefficient (ADC), which is altered in brain edema. ADC value reflects 
water mobility (expressed as µm
2
/sec) in the tissue. Changes in ADC can reflect the 
presence of cerebral oedema (Rovira et al. 2002; Schaefer 2000) that, in turn, can be 
vasogenic or cytotoxic. Cytotoxic oedema is accompanied by a decrease of ADC value 
(Schaefer et al. 2000) while vasogenic oedema is accompanied by an increase of ADC 
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value (McManus et al. 1995). In cytotoxic oedema ADC value decreases because water 
goes inside the cells where it cannot move as quickly as it can in the extracellular space. In 
vasogenic oedema, water content increases in the extracellular space leading to an increase 
of ADC value. Although children and youngest animals are more susceptible to lead-
induced brain oedema (Holtzman et al., 1982; Winder 1984) it has also been reported in the 
adult brain following acute or subacute lead exposure (Atre et al., 2006; Rojas-Marcos I et 
al., 2002; Saryan and Zenz 1994). To our knowledge, no studies have been performed yet 
to address whether chronic lead exposure elicits brain oedema in the adult brain and if 
different brain areas present different susceptibility to this effect.  
In this work we assessed: 
1) whether chronic lead exposure (0, 50, 500 ppm) in adults rats modifies ADC in 
different brain areas (motor cortex (MCx), somatosensory cortex (SCx), caudate-
putamen (CPu), hippocampus (Hip), mesencephalic reticular formation (RF), corpus 
callosum (CC) and cerebellum(Cb)).  
2) the time-course of these changes by measuring ADC in the same subjects at 
different time points during lead exposure (1, 4 and 12 weeks). 
3) If ADC alterations are accompanied by alterations of BBB permeability and water 
content. 
Water content was measured by wet-dry method and BBB permeability by Evans-blue 
extravasation method which has been extensively used to study BBB permeability 
(Hawkins and Davis 2005 for review). 
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MATERIALS AND METHODS 
Male Wistar rats (250-300 g) were used. Rats were given food and water ad libitum and 
kept in the air-conditioned experimental room at 21 – 23 oC with a 12:12 h light-dark cycle. 
Rats were divided into 3 groups: control rats drinking distillated water containing sodium 
acetate 50 or 500 ppm (N=3 each); lead acetate 50 ppm dissolved in the drinking water 
(N=6); lead acetate 500 ppm dissolved in the drinking water (N=6). New solutions of lead 
acetate were prepared daily and acidified with chloridric acid (final pH 7) to avoid 
precipitation. The animal experiments were approved by the Center and met the guidelines 
of the European Community for care and management of experimental animals. Body 
weights were measured once per week and fluid intake every three days. After 12 weeks of 
lead exposure rats were injected with Evans blue (see below) and sacrificed one hour later. 
With the help of coronal slicer matrix (1 mm thickness slices) we isolated MCx, SCx, Hip, 
CPu, half of the Cb (cut along the vermis), half of CC (cut perpendicular to the coronal 
plane), half of the mesenchephalic RF (cut coronally at the level of the fourth ventricle) 
from one hemisphere to measure the concentration of Evans blue and lead while the other 
brain areas belonging to the other hemisphere were used for water determination. Since the 
amount of tissue of CC is low, prior tissue processing, 3 CC belonging to 3 different rats of 
the same experimental group were pooled together to measure Evans blue and lead. CC of 
remaining 3 rats were pooled together to determine water content. Data from control rats 
exposed to 50 or 500 ppm of sodium acetate produced similar results in each of the 
measurements performed in the study so the data were pooled together. 
Magnetic Resonance Imaging (MRI) experiments  
MRI experiments were performed on a Bruker Pharmascan system (Bruker Medical Gmbh, 
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Ettlingen, Germany) using a 7.0-T horizontal-bore superconducting magnet, equipped with 
a 
1
H selective birdcage resonator of 38 mm and a Bruker gradient insert with 90 mm of 
diameter (maximum intensity 36 G/cm). All data were acquired using a Hewlett-Packard 
console running Paravision software (Bruker Medical Gmbh, Ettlingen, Germany) 
operating on a Linux platform. Anesthesia was initiated by inhalation of oxygen (1 l/min) 
containing 4 % isofluorane and maintained during the experiment employing a mask and 2 
% isofluorane in O2. Animal temperature was maintained at approx. 37 ºC with a heated 
probe. The physiological state of the rats was monitored using a Biotrig physiological 
monitor (Bruker, Germany) that controlled the respiratory rate and body temperature.  
Apparent diffusion coefficient (ADC) mapping 
Diffusion-weighted imaging (DWI) measures the relative translational motion of water 
molecules across cell membrane, which is expressed as the apparent diffusion coefficient 
(ADC) value.  
The ADC maps were obtained based in diffusion weighted images and the following 
parameters: TR= 2500 ms, TE = 25 ms, Av = 1, diffusion gradient duration = 4 ms, 
diffusion gradient separation = 16 ms, acquisition matrix = 128×128 corresponding to an 
in-plane resolution of 312 x 312 μm2, b factors = 100, 400 and 1000 s/mm2. Maps were 
obtained by a linear fitting of the logarithm of signal intensity (S) versus the b factor 
according to the expression: 
Sb = S0 exp (-ADC×b) 
MRI signal intensity was analysed in the brain areas of interest by ADC values (µm
2
/sec) in 
the corresponding maps, after capturing images with Image J which calculates the mean 
value for all pixels contained in the selected brain region. The different brain regions were 
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identified according to the stereotaxic coordinates of the rat brain atlas and to online plates 
of the atlas (Paxinos and Watson 1996). The regions analysed were MCx, SCx, CPu, Hip, 
RF, CC and Cb. ADC measurements were performed in the same subjects at different time 
points (1, 4 and 12 weeks) in order to perform a longitudinal study.  
Measurement of blood-brain barrier permeability 
BBB permeability was quantitatively evaluated by measuring the amount of extravasated 
Evans blue dye in the tissue at 12 weeks of chronic lead exposure according to procedure 
described in Hawkins and Egleton (2006). Evan’s blue (2%, containing 18 g/l bovine serum 
albumin 4 mL/kg) was injected over 2 min into the left femoral vein; it was allowed to 
circulate for 60 min. After decapitation, the brain was removed and MCx, SCx, CPu, Hip, 
RF, CC and Cb were isolated. Brains areas were weighted and homogenized in five-fold 
volume of 50% trichloroacetic acid solution. The supernatant was obtained by 
centrifugation (10 min, 10,000×g, at 4 
o
C). Evans blue extravasation was quantified in the 
supernatants by measuring the fluorescence (excitation at 620 nm and emission at 680 nm) 
(Abraham et al., 1996). The amount of extravasated Evans blue dye was expressed as 
nanogram per gram of brain tissue. 
Evaluation of brain oedema  
Wet-dry weight determinations (a simple and sensitive assay to measure brain oedema) of 
control and lead acetate-exposed brains were performed 12 weeks after chronic lead 
exposure. MCx, SCx, CPu, Hip, RF, CC and Cb were quickly dissected and the initial 
weight of each sample (wet weight) was determined. Samples then were dried in an oven at 
110°C for 24 hours, and the respective dry weight for each specimen was obtained. Tissue 
water content was calculated as [(wet weight - dry weight)/wet weight] × 100% (Abe et 
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al.1988). 
Lead measurement 
The day after the last MRI scanning, rats were anesthetized with isoflurane, rapidly 
decapitated, blood was collected from the neck and brain areas (MCx, SCx, CPu, Hip, RF, 
CC and Cb) were immediately dissected, frozen on liquid nitrogen, and stored at -80 °C 
until analysis of lead content. Lead content in brains and blood was analyzed by the 
Inductive Coupled Plasma-Atomic Emission Spectrometry (ICPAES). Brain tissue (20-40 
mg) was first processed by wet digestion (20% nitric acid and microwave exposure). The 
detection level of the method was 1.5 µg/kg wet-weight. For blood lead analysis, an aliquot 
of blood (100 µl) were first diluted ten times with 0.1% triton X-100/nitric acid. 
Statistical analysis 
The results are presented as mean ± standard error of mean (S.E.M.). The data were 
analyzed by one-way ANOVA followed Dunnett T-test or two-way ANOVA followed 
Bonferroni post-hoc test. p values lower than 0.05 were considered statistically significant. 
Statistical analysis was performed using the Graph Pad Prism 5 software (GraphPad 
Software Inc. San Diego, CA, USA). 
RESULTS 
Body weight, daily Pb fluid intake. 
No statistically differences in the gain of body weight of rats among the experimental 
groups were observed (control 380±37; lead 50 ppm 370±44; lead 500 ppm 338±31). The 
average daily intake of lead was 4.2 and 44 mg Pb/kg/day for the group drinking water 
containing 50 and 500 ppm, respectively. No significant differences of fluid intake were 
observed among experimental groups. Pb intake in the control group (sodium acetate in the 
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drinking water) was below the limit detection. 
 
Apparent diffusion coefficient  
ADC values after one week of lead exposure 
2-way analysis of variance of ADC values after one week of lead acetate exposure (50 or 
500 ppm) shows no significant effect of dose (F (2,105)= 0.097; p=0.9903), a significant 
effect of the brain region (F (6,105)= 140.6; p <0.0001) and no significant dose X brain 
region interaction (F(12,105)= 0.5524; p=0.8750). The significant effect of brain region 
was due the lowest values of ADC in CC (p<0.001), a pure white matter region. Each value 
is the mean of N=6 rats. (Table 1). 
ADC values after four weeks of lead exposure 
2-way analysis of variance of ADC values after four weeks of lead acetate exposure (50 or 
500 ppm)  shows a significant effect of dose (F (2,105)= 6.70; P<0.0018), a significant 
effect of the brain region (F (6,105)= 167; p <0.0001) and a significant dose X brain region 
interaction (F (12,105)= 2.32; p<0.0113). Bonferroni post-hoc test shows that exposure to 
lead acetate 500 ppm in the drinking water significantly increased ADC value in Hip, RF 
and Cb (p<0.05,p<0.01, p< 0.05  respectively) as compared to the ADC value of Hip, RF 
and Cb in the vehicle group. ADC values of CC were significantly lower as compared to 
ADC values of other brain regions but lead exposure did not significantly modify ADC 
value in CC. Exposure to 50 ppm lead acetate did not produce any significant change of 
ADC values in any of the brain region examined (Table 2). Each value is the mean of N=6 
rats. 
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ADC values after twelve weeks of lead exposure 
2-way analysis of variance of ADC values after twelve weeks of lead acetate exposure (50 
or 500 ppm) shows a significant effect of dose (F (2,105= 19.63; P<0.0001), a significant 
effect of the brain region (F (8,105)= 170.2; p <0.0001) and a  significant dose X brain 
region interaction (F (12,105)= 2.45; p=0.0074). Bonferroni post-hoc test shows that 
exposure to lead acetate 50 ppm in the drinking water significantly increased ADC value in 
RF (p<0.05) and in Cb (p<0.05) as compared to the ADC value of RF and of Cb in the 
vehicle group. Bonferroni post-hoc test shows that exposure to lead acetate 500 ppm in the 
drinking water significantly increased ADC value in CPu (p<0.01), Hip (p<0.05), RF 
(p<0.01), CC (p<0.05) and Cb (p<0.05) as compared to ADC values in the corresponding 
brain areas in the vehicle group. Moreover Bonferroni post-hoc test shows significant 
differences between ADC values of Hip, CPu and CC in rats exposed to 500 ppm lead 
acetate compared to ADC values of Hip, CPu and CC of rats exposed to 50 ppm  (p<0.05 
for Hip and CC and p < 0.01 for CPu). Each value is the mean of N=6 rats. (Table 3). 
Representative MRI scans showing ADC changes are reported in Figure 1. 
Determination of water content. 
In order to assess whether changes in ADC induced by lead exposure reflect the presence of 
cerebral oedema we determined water content (expressed as percentage of water in brain 
tissue) 12 weeks after lead acetate exposure (50 or 500 ppm in the drinking water) in the 
same brain areas analyzed by MRI (Figure 2). 2-way analysis of variance of water content 
data shows a significant effect of dose (F (2,93= 13.94; p<0.0001), a significant effect of 
the brain region (F (6,93)= 3.03; p <0.01) and a no significant dose X brain region 
interaction (F (12,93)= 1.69; p=0.08). Bonferroni post-hoc test shows that exposure to lead 
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acetate at 500 ppm in the drinking water significantly increased water content in CPu 
(p<0.05), Hip (p< 0.01), RF  (p< 0.05), CC (p< 0.01) and in Cb (p< 0.05) compared to  
water content in the corresponding brain areas in control rats. No significant differences 
were observed between water content in the group exposed to 50 ppm lead acetate 
compared to vehicle group (Figure 2). 
Blood Brain Barrier permeability. 
In order to evaluate if ADC changes induced by chronic lead acetate (50 or 500 ppm in the 
drinking water) were accompanied by alteration of BBB permeability we injected the 
fluorescent dye one hour before sacrifying the rats after 12 weeks of lead exposure. Evans 
blue was determined in the 7 brain areas and results expressed as µg of Evans blue/g tissue 
(Figure 3). 2-way analysis of variance of BBB permeability data shows a significant effect 
of dose (F (2,93= 39.44; p<0.0001), a significant effect of the brain region (F (6,93)= 6.21; 
p <0.0001) and a significant dose X brain region interaction (F (12,93)= 2.65; p=0.004). 
Bonferroni post-hoc test shows that exposure to lead acetate at 50 ppm in the drinking 
water significantly increased BBB permeability in the RF (p< 0.05), and in Cb (p< 0.05) 
compared to values of RF and Cb in control rats.   
Bonferroni post-hoc test shows that exposure to 500 ppm lead acetate in the drinking water 
significantly increased BBB permeability in CPu (p<0.001), Hip (p< 0.05), RF (p<  0.01), 
CC (p< 0.05) and in Cb (p< 0.001) compared to the corresponding values in control rats.   
Lead levels in blood and in brain areas 
In order to assess whether results obtained for ADC values, water content and BBB 
permeability in different brain areas (MCx, SCx, CPu, Hip, RF, CC and Cb) were due to 
different lead concentrations, we analyzed lead content in each brain area (expressed as 
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µg/g tissue) (Figure 4). Two-way analysis of variance shows a significant effect of dose (F 
(2, 93) = 368.9; p<0.0001), a significant effect of the brain region (F (6, 93) =3.70; p 
=0.0024) and a significant dose X brain region interaction (F (12, 93) = 2.16; p=0.02). 
Bonferroni post-hoc analysis showed that after 12 weeks exposure to 50 ppm or 500 ppm  
lead acetate there is a significant increase of lead content in all brain regions compared to 
vehicle group (p values between p< 0.01 and p<0.0001). In order to assess whether region-
specific differences in lead concentration correlate with the extent of the edema we 
performed linear regression analysis. No significant correlation was found between lead 
content and ADC increases (R
2
= 0.1532; p=0.17) or between lead content and water 
content (R
2
= 0.2161; p=0.09).  
Blood lead concentration was significantly increased in lead exposed rats in a dose-
dependent manner: in control it was below limit of detection in 3 rats and mean 2±0.3 
µg/dL in the other 3 rats, in the group of rats exposed to 50 ppm blood lead concentration 
was were 12.3±2.2 µg/dL and in those exposed to 500 ppm it was 55.4±8.6 µg/dL. These 
lead concentrations are clinically relevant (Cory-Slechta, 1995; Kala and Jadhav, 1995).  
Discussion  
Magnetic resonance imaging (MRI) is the most important imaging modality to follow 
pathology non-invasively in the central nervous system since it allows to perform 
longitudinal studies and to access to anatomical information. The high spatial resolution of 
MRI can faithfully depict the state of pathology through different mechanisms. Diffusion-
weighted imaging measures the relative translational motion of water molecules across cell 
membrane, which is expressed by ADC. Changes in ADC can be due to brain oedema 
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(Cauli et al. 2007 and 2010; Charles-Edwards and de Souza 2006; Gass et al., 2001; 
Schaefer 2000; Rovira et al. 2002). 
Our results showed that chronic lead exposure in adult rats increased ADC value in 
different brain areas such as CPu, Hip, RF, CC and Cb. However this effect was time- , 
dose- and brain region-dependent. Increases in ADC value were observed in 3 brain areas 
(Hip, RF and Cb) after 4 weeks of 500 ppm lead exposure whereas exposure for 12 weeks 
of lead acetate modified ADC value in 5 brain regions (Hip, RF, Cb, CPu and CC ) in  rats 
exposed to 500 ppm. Exposure to 50 ppm lead acetate for 12 weeks increased ADC only in 
2 brain regions (RF and Cb). In order to evaluate if ADC increases were due to cerebral 
oedema we measured water content at the end of longitudinal MRI studies. Those brain 
areas showing an increase of ADC also showed an increase of water content thus, 
confirming previous findings demonstrating that cerebral oedema can alter ADC value 
(Beaumont et al., 2000; Cauli et al. 2010; Kuroiwa et al., 1998). Exposure to 50 ppm 
increased ADC in RF and Cb but it did not significantly increase water content in these two 
brain areas although a trend was observed. Likely, sensitivity of ADC measurement to 
detect subtle changes in water diffusivity is greater than water content measurement by wet 
dry method. Interestingly, regions of cerebral cortex (MCx and SCx) showed no changes in 
ADC or in water content after lead exposure, an effect that was not related to a lower lead 
accumulation in these brain areas. In agreement with our findings, neonatal rats exposed to 
4% lead carbonate from postnatal day 12 until postnatal day 27 developed brain oedema in 
the cerebellum but not in the cerebral cortex (Hossain et al., 2004). One study performed by 
El-Neweshy et al. (2010) showed cerebellar oedema in rats chronically exposed to lead 
acetate for 60 days by daily intra-gastric administrations (20mg/kg). In contrast to adult and 
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newborn rats, prenatal exposure to lead (160 or 320 ppm of lead acetate solution during 21 
days through drinking water) induced vasogenic oedema in brain fetuses in many brain 
regions including the parietal cortex (Villeda-Hernández et al., 2006) thus suggesting that 
mechanisms that modulate brain region susceptibility to lead are different between prenatal 
and postnatal period. 
Those brain areas with increased ADC values displayed also an increase of Evans blue 
extravasation thus suggesting that increase of BBB permeability might play a role in the 
induction of vasogenic oedema.  
The link between increase of ADC, vasogenic oedema and increased BBB permeability has 
been demonstrated in several pathologies of the CNS (Cauli et al., 2010; Chen et al., 2007; 
Kleindienst et al. 2006; Rother et al., 1996). Cerebellar oedema in newborn rats exposed to 
lead was accompanied by leakage of albumin across the BBB (Hossain et al., 2004). 
Increased BBB permeability has also been observed in weaning rats chronically exposed to 
lead for 6 weeks (342 ug Pb/mL) (Wang et al., 2007) or in newborn rats exposed to daily 
i.p. injections of lead nitrate 10 mg/kg body weight  for the first 15 days of life (Sundstrom 
and Kalimo 1987; Sundstrom et al., 1985).  
Struzynska et al., (1997) showed the BBB permeability to vascular proteins was increased 
in rats exposed to lead in the drinking water for 3 months. This effect was accompanied by 
neuropathological alterations of BBB such enhanced pinocytic activity of endothelial cells 
and the opening of tight junction, and increased phagocytosis of perycites (Struzynska et 
al., 1997). The relationship between vasogenic oedema and increase in BBB permeability is 
also supported by the fact that MCx and SCx show no alteration in ADC and no increase in 
BBB permeability. The reason why cerebral cortex is not sensitive to the increase of ADC 
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value and BBB permeability induced by lead is unknown, future studies are needed to 
address this point.  
Consequences of vasogenic edema during lead exposure might include an increase in 
intracranial pressure that in turn may lead to alterations of regional cerebral blood flow 
(Milhorat et al., 1989) with impairment of nutrients and oxygen supply to affected brain 
regions or impaired ability to maintain neuronal excitability (Amiry-Moghaddam and 
Ottersen 2003; Broberg et al., 2008). 
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Legends to Figures 
Figure 1. ADC increase induced by chronic lead exposure. 
Figures show representative images of ADC maps in the hippocampus (Hip)  (images A-C 
indicated by two white arrows) and mesenchephalic reticular formation (RF) (images D-F 
indicated by the white arrow) after 12 weeks of lead acetate exposure via drinking water (0, 
50 ppm or 500 ppm). As shown in the picture, change of ADC in Hip is observed only after 
exposure to 500 ppm whereas hyperintensity of RF is observed after exposure to 50 and 
500 ppm (quantification of ADC values is shown in Table 3). Maps were quantified with 
Image J software as described in Material and Methods.   
 
Figure 2. Water content in rats chronically treated with lead acetate. 
After exposure to lead acetate (0,50 or 500 ppm) for 12 weeks in the drinking water rats 
were sacrified and water content was determined by wet dry method in each brain area as 
described in Material and Methods. Each values represent mean ± SEM of N=6 rats per 
group. * p<0.05 ** p < 0.01 as compared to control group (0 ppm). 
 
Figure 3. Blood brain barrier permeability in rats chronically treated with lead 
acetate. 
After exposure to lead acetate (0,50 or 500 ppm) for 12 weeks in the drinking water rats 
received an iv. injection of Evans-Blue albumin complex and were sacrified one hour later 
as described in Material and Methods. Each values represent mean ± SEM of N=6 rats per 
group. * p<0.05 ** p < 0.01 *** p < 0.001 as compared to control group (0 ppm). 
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Figure 4. Lead content in different brain areas in rats chronically treated with lead 
acetate. 
After exposure to lead acetate (0, 50 or 500 ppm) for 12 weeks in the drinking water rats 
were sacrified and lead content was determined in each brain area as described in Material 
and Methods. Each values represent mean ± SEM of N=6 rats per group. * p<0.05 ** p < 
0.01 *** p < 0.001 as compared to  control group (0 ppm). 
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ABSTRACT  
Diffusion-weighted imaging (DWI) allows the assessment of the water apparent diffusion 
coefficient (ADC), a measure of tissue water diffusivity which is altered during different 
pathological conditions such as cerebral oedema. By means of DWI, we repeatedly 
measured in the same rats apparent diffusion coefficient ADC in different brain areas 
(motor cortex (MCx), somato-sensory cortex (SCx), caudate-putamen (CPu), hippocampus 
(Hip), mesencephalic reticular formation (RF), corpus callosum (CC) and cerebellum (Cb)) 
after 1 week, 4 and 12 weeks of lead acetate exposure via drinking water (50 or 500 ppm). 
After 12 weeks of lead exposure rats received albumin-Evans blue complex administration 
and were sacrified one hour later. Blood-brain barrier permeability and water tissue content 
were determined in order to evaluate their relationship with ADC changes. Chronic 
exposure to lead acetate (500 ppm) for 4 weeks increased ADC values in Hip, RF and Cb 
but no in other brain areas. After 12 weeks of lead acetate exposure at 500 ppm ADC is 
significantly increased also in CPu and CC. Brain areas displaying high ADC values after 
lead exposure showed also an increased water content and increased BBB permeability to 
Evans blue-albumin complex. Exposure to 50 ppm for 12 weeks increased ADC values and 
BBB permeability in the RF and Cb. In summary, chronic lead exposure induces cerebral 
oedema in the adult brain depending on the brain area and the dose of exposure. RF and Cb 
appeared the most sensitive brain areas whereas cerebral cortex appears resistant to lead-
induced cerebral oedema. 
KEY WORDS: lead neurotoxicity, vasogenic oedema, blood-brain barrier, reticular 
formation, apparent diffusion coefficient, magnetic resonance imaging  
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Introduction 
Lead (Pb) neurotoxicity is still a major medical concern in both environmental and 
occupational settings (CDC 2000). The clinical effects of acute and chronic lead toxicity 
are well documented (Davis et al. 1993, Grandjean 1993). Acute lead intoxication induces 
oedema in the brain of humans and laboratory animals (Goldstein et al., 1974; Holtzman et 
al., 1982; Hossain et al., 2004; Lögdberg et al., 1988; Pentschew, 1965; Villeda-Hernández 
et al., 2006; Winder et al., 1983; Winder 1984 for review). Two main types of cerebral 
oedema have been described, namely, vasogenic and cytotoxic oedema. Vasogenic oedema 
can be induced when water entries into the brain following an alteration of blood-brain 
barrier (BBB) permeability thus leading to an accumulation of water in the extracellular 
space (Klatzo 1967). In cytotoxic oedema (also called cellular oedema), water 
accumulation occurs inside the cells mainly in astrocytes (Klatzo 1967). 
It has been reported that acute lead intoxication in children and perinatal lead exposure in 
young animals cause cerebral oedema, in particular, vasogenic oedema (Hossain et al., 
2004; Lefauconnier  et al., 1983;Villeda-Hernández et al., 2006). Cytotoxic oedema has 
also been reported in one study (Lefauconnier et al., 1983). Different brain areas display 
different vulnerability to lead-induced cerebral oedema in young animals. Lead exposure 
(160 or 320 ppm in the drinking water) from gestational day 1 to gestational day 21 dose-
dependently induce interstitial/vasogenic oedema in different brain regions of rat fetuses 
such as parietal cortex, striatum, thalamus and cerebellum (Villeda-Hernandez et al., 2006) 
while Hossain et al. (2004) reported that cerebellum is the more susceptible brain region to 
lead-induced oedema in newborn rats. One of the events that contribute to vasogenic 
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4 
oedema formation in the brain is the increase of BBB permeability.  
Vasogenic oedema resulting from BBB failure causes transvascular leak of blood proteins 
(albumin, fibrinogen, fibronectin and immunoglobulins) with concurrent oncotic influx of 
water and failure of compensatory mechanisms of fluid homeostasis. According to the 
proposed link between alteration of BBB permeability and the occurrence of vasogenic 
oedema, it has been shown in young animals that lead exposure impairs BBB permeability 
(Hossain et al., 2004; Sundstrom and Kalimo 1987; Sundstrom et al., 1985; Wang et al., 
2007). 
Moreover, several reports have demonstrated that lead accumulates not only in BBB 
endothelial cells (Struzynska et al., 1997; Toews et al., 1978) but also in the choroid plexus 
(Friedheim et al., 1983; Manton et al., 1984; Zheng et al., 1991) where it increases the 
leakage of the blood-cerebrospinal fluid barrier (Shi and Zheng 2007). These findings 
suggest that the mechanisms involved in brain water homeostasis might be altered during 
lead exposure. 
Magnetic resonance imaging (MRI) is a non invasive tool that provides information about 
changes in cerebral function in brain in vivo. MRI is the ideal modality to characterize the 
temporal and spatial evolutions of neuropathologies in vivo. Among different parameters 
that could be analyzed by MRI, diffusion weighted imaging (DWI) allows to calculate the 
apparent diffusion coefficient (ADC), which is altered in brain edema. ADC value reflects 
water mobility (expressed as µm
2
/sec) in the tissue. Changes in ADC can reflect the 
presence of cerebral oedema (Rovira et al. 2002; Schaefer 2000) that, in turn, can be 
vasogenic or cytotoxic. Cytotoxic oedema is accompanied by a decrease of ADC value 
(Schaefer et al. 2000) while vasogenic oedema is accompanied by an increase of ADC 
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value (McManus et al. 1995). In cytotoxic oedema ADC value decreases because water 
goes inside the cells where it cannot move as quickly as it can in the extracellular space. In 
vasogenic oedema, water content increases in the extracellular space leading to an increase 
of ADC value. Although children and youngest animals are more susceptible to lead-
induced brain oedema (Holtzman et al., 1982; Winder 1984) it has also been reported in the 
adult brain following acute or subacute lead exposure (Atre et al., 2006; Rojas-Marcos I et 
al., 2002; Saryan and Zenz 1994). To our knowledge, no studies have been performed yet 
to address whether chronic lead exposure elicits brain oedema in the adult brain and if 
different brain areas present different susceptibility to this effect.  
In this work we assessed: 
1) whether chronic lead exposure (0, 50, 500 ppm) in adults rats modifies ADC in 
different brain areas (motor cortex (MCx), somatosensory cortex (SCx), caudate-
putamen (CPu), hippocampus (Hip), mesencephalic reticular formation (RF), corpus 
callosum (CC) and cerebellum(Cb)).  
2) the time-course of these changes by measuring ADC in the same subjects at 
different time points during lead exposure (1, 4 and 12 weeks). 
3) If ADC alterations are accompanied by alterations of BBB permeability and water 
content. 
Water content was measured by wet-dry method and BBB permeability by Evans-blue 
extravasation method which has been extensively used to study BBB permeability 
(Hawkins and Davis 2005 for review). 
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MATERIALS AND METHODS 
Male Wistar rats (250-300 g) were used. Rats were given food and water ad libitum and 
kept in the air-conditioned experimental room at 21 – 23 oC with a 12:12 h light-dark cycle. 
Rats were divided into 3 groups: control rats drinking distillated water containing sodium 
acetate 50 or 500 ppm (N=3 each); lead acetate 50 ppm dissolved in the drinking water 
(N=6); lead acetate 500 ppm dissolved in the drinking water (N=6). New solutions of lead 
acetate were prepared daily and acidified with chloridric acid (final pH 7) to avoid 
precipitation. The animal experiments were approved by the Center and met the guidelines 
of the European Community for care and management of experimental animals. Body 
weights were measured once per week and fluid intake every three days. After 12 weeks of 
lead exposure rats were injected with Evans blue (see below) and sacrificed one hour later. 
With the help of coronal slicer matrix (1 mm thickness slices) we isolated MCx, SCx, Hip, 
CPu, half of the Cb (cut along the vermis), half of CC (cut perpendicular to the coronal 
plane), half of the mesenchephalic RF (cut coronally at the level of the fourth ventricle) 
from one hemisphere to measure the concentration of Evans blue and lead while the other 
brain areas belonging to the other hemisphere were used for water determination. Since the 
amount of tissue of CC is low, prior tissue processing, 3 CC belonging to 3 different rats of 
the same experimental group were pooled together to measure Evans blue and lead. CC of 
remaining 3 rats were pooled together to determine water content. Data from control rats 
exposed to 50 or 500 ppm of sodium acetate produced similar results in each of the 
measurements performed in the study so the data were pooled together. 
Magnetic Resonance Imaging (MRI) experiments  
MRI experiments were performed on a Bruker Pharmascan system (Bruker Medical Gmbh, 
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7 
Ettlingen, Germany) using a 7.0-T horizontal-bore superconducting magnet, equipped with 
a 
1
H selective birdcage resonator of 38 mm and a Bruker gradient insert with 90 mm of 
diameter (maximum intensity 36 G/cm). All data were acquired using a Hewlett-Packard 
console running Paravision software (Bruker Medical Gmbh, Ettlingen, Germany) 
operating on a Linux platform. Anesthesia was initiated by inhalation of oxygen (1 l/min) 
containing 4 % isofluorane and maintained during the experiment employing a mask and 2 
% isofluorane in O2. Animal temperature was maintained at approx. 37 ºC with a heated 
probe. The physiological state of the rats was monitored using a Biotrig physiological 
monitor (Bruker, Germany) that controlled the respiratory rate and body temperature.  
Apparent diffusion coefficient (ADC) mapping 
Diffusion-weighted imaging (DWI) measures the relative translational motion of water 
molecules across cell membrane, which is expressed as the apparent diffusion coefficient 
(ADC) value.  
The ADC maps were obtained based in diffusion weighted images and the following 
parameters: TR= 2500 ms, TE = 25 ms, Av = 1, diffusion gradient duration = 4 ms, 
diffusion gradient separation = 16 ms, acquisition matrix = 128×128 corresponding to an 
in-plane resolution of 312 x 312 μm2, b factors = 100, 400 and 1000 s/mm2. Maps were 
obtained by a linear fitting of the logarithm of signal intensity (S) versus the b factor 
according to the expression: 
Sb = S0 exp (-ADC×b) 
MRI signal intensity was analysed in the brain areas of interest by ADC values (µm
2
/sec) in 
the corresponding maps, after capturing images with Image J which calculates the mean 
value for all pixels contained in the selected brain region. The different brain regions were 
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8 
identified according to the stereotaxic coordinates of the rat brain atlas and to online plates 
of the atlas (Paxinos and Watson 1996). The regions analysed were MCx, SCx, CPu, Hip, 
RF, CC and Cb. ADC measurements were performed in the same subjects at different time 
points (1, 4 and 12 weeks) in order to perform a longitudinal study.  
Measurement of blood-brain barrier permeability 
BBB permeability was quantitatively evaluated by measuring the amount of extravasated 
Evans blue dye in the tissue at 12 weeks of chronic lead exposure according to procedure 
described in Hawkins and Egleton (2006). Evan’s blue (2%, containing 18 g/l bovine serum 
albumin 4 mL/kg) was injected over 2 min into the left femoral vein; it was allowed to 
circulate for 60 min. After decapitation, the brain was removed and MCx, SCx, CPu, Hip, 
RF, CC and Cb were isolated. Brains areas were weighted and homogenized in five-fold 
volume of 50% trichloroacetic acid solution. The supernatant was obtained by 
centrifugation (10 min, 10,000×g, at 4 
o
C). Evans blue extravasation was quantified in the 
supernatants by measuring the fluorescence (excitation at 620 nm and emission at 680 nm) 
(Abraham et al., 1996). The amount of extravasated Evans blue dye was expressed as 
nanogram per gram of brain tissue. 
Evaluation of brain oedema  
Wet-dry weight determinations (a simple and sensitive assay to measure brain oedema) of 
control and lead acetate-exposed brains were performed 12 weeks after chronic lead 
exposure. MCx, SCx, CPu, Hip, RF, CC and Cb were quickly dissected and the initial 
weight of each sample (wet weight) was determined. Samples then were dried in an oven at 
110°C for 24 hours, and the respective dry weight for each specimen was obtained. Tissue 
water content was calculated as [(wet weight - dry weight)/wet weight] × 100% (Abe et 
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al.1988). 
Lead measurement 
The day after the last MRI scanning, rats were anesthetized with isoflurane, rapidly 
decapitated, blood was collected from the neck and brain areas (MCx, SCx, CPu, Hip, RF, 
CC and Cb) were immediately dissected, frozen on liquid nitrogen, and stored at -80 °C 
until analysis of lead content. Lead content in brains and blood was analyzed by the 
Inductive Coupled Plasma-Atomic Emission Spectrometry (ICPAES). Brain tissue (20-40 
mg) was first processed by wet digestion (20% nitric acid and microwave exposure). The 
detection level of the method was 1.5 µg/kg wet-weight. For blood lead analysis, an aliquot 
of blood (100 µl) were first diluted ten times with 0.1% triton X-100/nitric acid. 
Statistical analysis 
The results are presented as mean ± standard error of mean (S.E.M.). The data were 
analyzed by one-way ANOVA followed Dunnett T-test or two-way ANOVA followed 
Bonferroni post-hoc test. p values lower than 0.05 were considered statistically significant. 
Statistical analysis was performed using the Graph Pad Prism 5 software (GraphPad 
Software Inc. San Diego, CA, USA). 
RESULTS 
Body weight, daily Pb fluid intake. 
No statistically differences in the gain of body weight of rats among the experimental 
groups were observed (control 380±37; lead 50 ppm 370±44; lead 500 ppm 338±31). The 
average daily intake of lead was 4.2 and 44 mg Pb/kg/day for the group drinking water 
containing 50 and 500 ppm, respectively. No significant differences of fluid intake were 
observed among experimental groups. Pb intake in the control group (sodium acetate in the 
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drinking water) was below the limit detection. 
 
Apparent diffusion coefficient  
ADC values after one week of lead exposure 
2-way analysis of variance of ADC values after one week of lead acetate exposure (50 or 
500 ppm) shows no significant effect of dose (F (2,105)= 0.097; p=0.9903), a significant 
effect of the brain region (F (6,105)= 140.6; p <0.0001) and no significant dose X brain 
region interaction (F(12,105)= 0.5524; p=0.8750). The significant effect of brain region 
was due the lowest values of ADC in CC (p<0.001), a pure white matter region. Each value 
is the mean of N=6 rats. (Table 1). 
ADC values after four weeks of lead exposure 
2-way analysis of variance of ADC values after four weeks of lead acetate exposure (50 or 
500 ppm)  shows a significant effect of dose (F (2,105)= 6.70; P<0.0018), a significant 
effect of the brain region (F (6,105)= 167; p <0.0001) and a significant dose X brain region 
interaction (F (12,105)= 2.32; p<0.0113). Bonferroni post-hoc test shows that exposure to 
lead acetate 500 ppm in the drinking water significantly increased ADC value in Hip, RF 
and Cb (p<0.05,p<0.01, p< 0.05  respectively) as compared to the ADC value of Hip, RF 
and Cb in the vehicle group. ADC values of CC were significantly lower as compared to 
ADC values of other brain regions but lead exposure did not significantly modify ADC 
value in CC. Exposure to 50 ppm lead acetate did not produce any significant change of 
ADC values in any of the brain region examined (Table 2). Each value is the mean of N=6 
rats. 
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ADC values after twelve weeks of lead exposure 
2-way analysis of variance of ADC values after twelve weeks of lead acetate exposure (50 
or 500 ppm) shows a significant effect of dose (F (2,105= 19.63; P<0.0001), a significant 
effect of the brain region (F (8,105)= 170.2; p <0.0001) and a  significant dose X brain 
region interaction (F (12,105)= 2.45; p=0.0074). Bonferroni post-hoc test shows that 
exposure to lead acetate 50 ppm in the drinking water significantly increased ADC value in 
RF (p<0.05) and in Cb (p<0.05) as compared to the ADC value of RF and of Cb in the 
vehicle group. Bonferroni post-hoc test shows that exposure to lead acetate 500 ppm in the 
drinking water significantly increased ADC value in CPu (p<0.01), Hip (p<0.05), RF 
(p<0.01), CC (p<0.05) and Cb (p<0.05) as compared to ADC values in the corresponding 
brain areas in the vehicle group. Moreover Bonferroni post-hoc test shows significant 
differences between ADC values of Hip, CPu and CC in rats exposed to 500 ppm lead 
acetate compared to ADC values of Hip, CPu and CC of rats exposed to 50 ppm  (p<0.05 
for Hip and CC and p < 0.01 for CPu). Each value is the mean of N=6 rats. (Table 3). 
Representative MRI scans showing ADC changes are reported in Figure 1. 
Determination of water content. 
In order to assess whether changes in ADC induced by lead exposure reflect the presence of 
cerebral oedema we determined water content (expressed as percentage of water in brain 
tissue) 12 weeks after lead acetate exposure (50 or 500 ppm in the drinking water) in the 
same brain areas analyzed by MRI (Figure 2). 2-way analysis of variance of water content 
data shows a significant effect of dose (F (2,93= 13.94; p<0.0001), a significant effect of 
the brain region (F (6,93)= 3.03; p <0.01) and a no significant dose X brain region 
interaction (F (12,93)= 1.69; p=0.08). Bonferroni post-hoc test shows that exposure to lead 
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12 
acetate at 500 ppm in the drinking water significantly increased water content in CPu 
(p<0.05), Hip (p< 0.01), RF  (p< 0.05), CC (p< 0.01) and in Cb (p< 0.05) compared to  
water content in the corresponding brain areas in control rats. No significant differences 
were observed between water content in the group exposed to 50 ppm lead acetate 
compared to vehicle group (Figure 2). 
Blood Brain Barrier permeability. 
In order to evaluate if ADC changes induced by chronic lead acetate (50 or 500 ppm in the 
drinking water) were accompanied by alteration of BBB permeability we injected the 
fluorescent dye one hour before sacrifying the rats after 12 weeks of lead exposure. Evans 
blue was determined in the 7 brain areas and results expressed as µg of Evans blue/g tissue 
(Figure 3). 2-way analysis of variance of BBB permeability data shows a significant effect 
of dose (F (2,93= 39.44; p<0.0001), a significant effect of the brain region (F (6,93)= 6.21; 
p <0.0001) and a significant dose X brain region interaction (F (12,93)= 2.65; p=0.004). 
Bonferroni post-hoc test shows that exposure to lead acetate at 50 ppm in the drinking 
water significantly increased BBB permeability in the RF (p< 0.05), and in Cb (p< 0.05) 
compared to values of RF and Cb in control rats.   
Bonferroni post-hoc test shows that exposure to 500 ppm lead acetate in the drinking water 
significantly increased BBB permeability in CPu (p<0.001), Hip (p< 0.05), RF (p<  0.01), 
CC (p< 0.05) and in Cb (p< 0.001) compared to the corresponding values in control rats.   
Lead levels in blood and in brain areas 
In order to assess whether results obtained for ADC values, water content and BBB 
permeability in different brain areas (MCx, SCx, CPu, Hip, RF, CC and Cb) were due to 
different lead concentrations, we analyzed lead content in each brain area (expressed as 
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µg/g tissue) (Figure 4). Two-way analysis of variance shows a significant effect of dose (F 
(2, 93) = 368.9; p<0.0001), a significant effect of the brain region (F (6, 93) =3.70; p 
=0.0024) and a significant dose X brain region interaction (F (12, 93) = 2.16; p=0.02). 
Bonferroni post-hoc analysis showed that after 12 weeks exposure to 50 ppm or 500 ppm  
lead acetate there is a significant increase of lead content in all brain regions compared to 
vehicle group (p values between p< 0.01 and p<0.0001). In order to assess whether region-
specific differences in lead concentration correlate with the extent of the edema we 
performed linear regression analysis. No significant correlation was found between lead 
content and ADC increases (R
2
= 0.1532; p=0.17) or between lead content and water 
content (R
2
= 0.2161; p=0.09).  
Blood lead concentration was significantly increased in lead exposed rats in a dose-
dependent manner: in control it was below limit of detection in 3 rats and mean 2±0.3 
µg/dL in the other 3 rats, in the group of rats exposed to 50 ppm blood lead concentration 
was were 12.3±2.2 µg/dL and in those exposed to 500 ppm it was 55.4±8.6 µg/dL. These 
lead concentrations are clinically relevant (Cory-Slechta, 1995; Kala and Jadhav, 1995).  
Discussion  
Magnetic resonance imaging (MRI) is the most important imaging modality to follow 
pathology non-invasively in the central nervous system since it allows to perform 
longitudinal studies and to access to anatomical information. The high spatial resolution of 
MRI can faithfully depict the state of pathology through different mechanisms. Diffusion-
weighted imaging measures the relative translational motion of water molecules across cell 
membrane, which is expressed by ADC. Changes in ADC can be due to brain oedema 
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14 
(Cauli et al. 2007 and 2010; Charles-Edwards and de Souza 2006; Gass et al., 2001; 
Schaefer 2000; Rovira et al. 2002). 
Our results showed that chronic lead exposure in adult rats increased ADC value in 
different brain areas such as CPu, Hip, RF, CC and Cb. However this effect was time- , 
dose- and brain region-dependent. Increases in ADC value were observed in 3 brain areas 
(Hip, RF and Cb) after 4 weeks of 500 ppm lead exposure whereas exposure for 12 weeks 
of lead acetate modified ADC value in 5 brain regions (Hip, RF, Cb, CPu and CC ) in  rats 
exposed to 500 ppm. Exposure to 50 ppm lead acetate for 12 weeks increased ADC only in 
2 brain regions (RF and Cb). In order to evaluate if ADC increases were due to cerebral 
oedema we measured water content at the end of longitudinal MRI studies. Those brain 
areas showing an increase of ADC also showed an increase of water content thus, 
confirming previous findings demonstrating that cerebral oedema can alter ADC value 
(Beaumont et al., 2000; Cauli et al. 2010; Kuroiwa et al., 1998). Exposure to 50 ppm 
increased ADC in RF and Cb but it did not significantly increase water content in these two 
brain areas although a trend was observed. Likely, sensitivity of ADC measurement to 
detect subtle changes in water diffusivity is greater than water content measurement by wet 
dry method. Interestingly, regions of cerebral cortex (MCx and SCx) showed no changes in 
ADC or in water content after lead exposure, an effect that was not related to a lower lead 
accumulation in these brain areas. In agreement with our findings, neonatal rats exposed to 
4% lead carbonate from postnatal day 12 until postnatal day 27 developed brain oedema in 
the cerebellum but not in the cerebral cortex (Hossain et al., 2004). One study performed by 
El-Neweshy et al. (2010) showed cerebellar oedema in rats chronically exposed to lead 
acetate for 60 days by daily intra-gastric administrations (20mg/kg). In contrast to adult and 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
15 
newborn rats, prenatal exposure to lead (160 or 320 ppm of lead acetate solution during 21 
days through drinking water) induced vasogenic oedema in brain fetuses in many brain 
regions including the parietal cortex (Villeda-Hernández et al., 2006) thus suggesting that 
mechanisms that modulate brain region susceptibility to lead are different between prenatal 
and postnatal period. 
Those brain areas with increased ADC values displayed also an increase of Evans blue 
extravasation thus suggesting that increase of BBB permeability might play a role in the 
induction of vasogenic oedema.  
The link between increase of ADC, vasogenic oedema and increased BBB permeability has 
been demonstrated in several pathologies of the CNS (Cauli et al., 2010; Chen et al., 2007; 
Kleindienst et al. 2006; Rother et al., 1996). Cerebellar oedema in newborn rats exposed to 
lead was accompanied by leakage of albumin across the BBB (Hossain et al., 2004). 
Increased BBB permeability has also been observed in weaning rats chronically exposed to 
lead for 6 weeks (342 ug Pb/mL) (Wang et al., 2007) or in newborn rats exposed to daily 
i.p. injections of lead nitrate 10 mg/kg body weight  for the first 15 days of life (Sundstrom 
and Kalimo 1987; Sundstrom et al., 1985).  
Struzynska et al., (1997) showed the BBB permeability to vascular proteins was increased 
in rats exposed to lead in the drinking water for 3 months. This effect was accompanied by 
neuropathological alterations of BBB such enhanced pinocytic activity of endothelial cells 
and the opening of tight junction, and increased phagocytosis of perycites (Struzynska et 
al., 1997). The relationship between vasogenic oedema and increase in BBB permeability is 
also supported by the fact that MCx and SCx show no alteration in ADC and no increase in 
BBB permeability. The reason why cerebral cortex is not sensitive to the increase of ADC 
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value and BBB permeability induced by lead is unknown, future studies are needed to 
address this point.  
Consequences of vasogenic edema during lead exposure might include an increase in 
intracranial pressure that in turn may lead to alterations of regional cerebral blood flow 
(Milhorat et al., 1989) with impairment of nutrients and oxygen supply to affected brain 
regions or impaired ability to maintain neuronal excitability (Amiry-Moghaddam and 
Ottersen 2003; Broberg et al., 2008). 
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Legends to Figures 
Figure 1. ADC increase induced by chronic lead exposure. 
Figures show representative images of ADC maps in the hippocampus (Hip)  (images A-C 
indicated by two white arrows) and mesenchephalic reticular formation (RF) (images D-F 
indicated by the white arrow) after 12 weeks of lead acetate exposure via drinking water (0, 
50 ppm or 500 ppm). As shown in the picture, change of ADC in Hip is observed only after 
exposure to 500 ppm whereas hyperintensity of RF is observed after exposure to 50 and 
500 ppm (quantification of ADC values is shown in Table 3). Maps were quantified with 
Image J software as described in Material and Methods.   
 
Figure 2. Water content in rats chronically treated with lead acetate. 
After exposure to lead acetate (0,50 or 500 ppm) for 12 weeks in the drinking water rats 
were sacrified and water content was determined by wet dry method in each brain area as 
described in Material and Methods. Each values represent mean ± SEM of N=6 rats per 
group. * p<0.05 ** p < 0.01 as compared to control group (0 ppm). 
 
Figure 3. Blood brain barrier permeability in rats chronically treated with lead 
acetate. 
After exposure to lead acetate (0,50 or 500 ppm) for 12 weeks in the drinking water rats 
received an iv. injection of Evans-Blue albumin complex and were sacrified one hour later 
as described in Material and Methods. Each values represent mean ± SEM of N=6 rats per 
group. * p<0.05 ** p < 0.01 *** p < 0.001 as compared to control group (0 ppm). 
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Figure 4. Lead content in different brain areas in rats chronically treated with lead 
acetate. 
After exposure to lead acetate (0, 50 or 500 ppm) for 12 weeks in the drinking water rats 
were sacrified and lead content was determined in each brain area as described in Material 
and Methods. Each values represent mean ± SEM of N=6 rats per group. * p<0.05 ** p < 
0.01 *** p < 0.001 as compared to  control group (0 ppm). 
 
Table 1. ADC  values (x 10
(-1)
 µm
2
/sec) in different brain areas after lead acetate 
exposure (0, 50, 500 ppm) in the drinking water for 1 week. 
Brain area 
 
0 ppm 
 
50 ppm 500 ppm 
MCx 8465±194 8235±124 8350±139 
SCx 8322±155 8197±194 8108±201 
CPu 8104±165 8216±138 8378±188  
Hip 9245±170 9326±186 9384±189 
RF 9985±114 9816±174 10064±182 
CC 7002±120 7147±105 6958±108 
Cb 10011±138 10166±183 10247±144 
Rats were exposed via the drinking water to sodium acetate (0 ppm), or one of the 
concentrations of lead acetate (50 ppm or 500 ppm). 1 week after exposure they were 
anaesthetized and subjected to MRI as described in Methods. ADC values were 
calculated in the following brain regions: motor cortex (MCx), somato-sensory cortex 
(SCx), caudate-putamen (Cpu), hippocampus (Hip), mesencephalic reticular formation 
(RF), corpus callosum (CC) and cerebellum (Cb). Values are the mean  SEM of six 
rats per group. Values that are significantly different from control are indicated by 
asterisks * p < 0.05. 
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Table 2. ADC values (x 10
(-1)
 µm
2
/sec) in different brain areas after lead acetate 
exposure (0, 50, 500 ppm) in the drinking water for 4 weeks. 
Brain area 
 
0 ppm 
 
50 ppm 500 ppm 
MCx 8542±150 8281±156 8493±185 
SCx 8245±147 8188±171 8145±178 
CPu 8004±202 8048±156 8207±252  
Hip 9499±126 9584±133 9962±154* 
RF 10042±145 10016±198 10454±177** 
CC 7058±84 7120±111 7156±105 
Cb 10068±114 10040±174 10411±106* 
 
Rats were exposed via the drinking water sodium acetate (0 ppm), or one of the 
concentrations of lead acetate (50 ppm or 500 ppm). 4 weeks (± 3 days) after exposure 
there were anaesthetized and subjected to MRI as described in Methods. ADC values 
were calculated in the following brain regions: motor cortex (MCx), somato-sensory 
cortex (SCx), caudate-putamen (Cpu), hippocampus (Hip), mesencephalic reticular 
formation (RF), corpus callosum (CC) and cerebellum (Cb). Values are the mean  
SEM of six rats per group. Values that are significantly different from control are 
indicated by asterisks * p < 0.05; ** p < 0.01. 
 
 
 
 
Table 3. ADC values (x 10
(-1)
 µm
2
/sec) in different brain areas after lead acetate 
exposure (0, 50, 500 ppm) in the drinking water for 12 weeks. 
Brain area 
 
0 ppm 
 
50 ppm 500 ppm 
MCx 8377±165 8240±131 8403±154 
SCx 8305±158 8285±186 8461±150 
CPu 8155±173 8289±171 8502±206 * 
Hip 9256±138 9156±165 9874±117* 
RF 10125±178 10565±164* 11065±191** 
CC 7247±97 7356±131 7655±127* 
Cb 10145±117 10454±164* 10647±126* 
 
Rats were exposed via the drinking water sodium acetate (0 ppm), or one of the 
concentrations of lead acetate (50 ppm or 500 ppm). 10 weeks (± 4 days) after exposure 
there were anaesthetized and subjected to MRI as described in Methods. ADC values 
were calculated in the following brain regions motor cortex (MCx), somato-sensory 
cortex (SCx), caudate-putamen (Cpu), hippocampus (Hip), mesencephalic reticular 
formation (RF), corpus callosum (CC) and cerebellum (Cb). Values are the mean  
SEM of six rats per group. Values that are significantly different from control are 
indicated by asterisks * p < 0.05. 
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